GENEVA, Dec. 17 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215) filed a patent application (PCT/US2025/032047) for "CYCLOALKYL AND HETEROCYCLIC MODULATORS OF TNF ACTIVITY" on Jun 03, 2025. With publication no. WO/2025/255096, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JONES, Lyn Howard (c/o Dana-Farber Cancer Institute, Inc.450 Brookline AvenueBoston, Massachusetts 02215), HUANG, Huang (c/o Dana-Farber Cancer Institute, Inc.450 Brookline AvenueBoston, Massachusetts 02215), LIU,...